Bristol Myers Squibb & Co (NYSE:BMY) reported second-quarter 2025 revenues of $12.27 billion, beating the consensus of $11.31 ...

More deals are likely coming down the pipeline for Biogen Inc. as the company looks to build out its early-stage pipeline.

Lincoln National (LNC) posts strong Q2 2025 results with 32% YoY income growth, record group margins, and strategic capital deployment initiatives.

President Trump is considering whether to encourage retirement funds to invest in private equity, a financial sector that’s ...

Bain Capital and KKR are among three groups preparing bids for Sapporo Holdings' real estate business, valued at approximately $2.7 billion. Sapporo is selling its real estate hol ...

Seoul – Hyosung Advanced Materials Corp. (HAMC) has confirmed Bain Capital Private Equity (Asia) LLC as the preferred bidder for its steel tire cord business, for the possible KRW 1.5 trillion (€1.0 ...

The three groups preparing to bid are Lone Star and Kenedix, Bain and Tokyu Fudosan, and KKR, PAG and Nomura Real Estate, two ...

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

Nebulock was created to solve a glaring problem: organizations outside the Fortune 100 lack the resources and skills for proactive threat hunting. Threat hunting workflows take weeks to execute, and ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...